171 related articles for article (PubMed ID: 30249026)
1. Exposure of Breast and Lung Cancer Cells to a Novel Estrone Analog Prior to Radiation Enhances Bcl-2-Mediated Cell Death.
Nolte EM; Joubert AM; Lakier R; van Rensburg A; Mercier AE
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30249026
[TBL] [Abstract][Full Text] [Related]
2. 2-Methoxyestradiol, an endogenous estrogen metabolite, sensitizes radioresistant MCF-7/FIR breast cancer cells through multiple mechanisms.
Salama S; Diaz-Arrastia C; Patel D; Botting S; Hatch S
Int J Radiat Oncol Biol Phys; 2011 May; 80(1):231-9. PubMed ID: 21392897
[TBL] [Abstract][Full Text] [Related]
3. Radiosensitization of Breast Cancer Cells with a 2-Methoxyestradiol Analogue Affects DNA Damage and Repair Signaling In Vitro.
Nolte EM; Joubert AM; Lafanechère L; Mercier AE
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835001
[TBL] [Abstract][Full Text] [Related]
4. In vitro assessment of a computer-designed potential anticancer agent in cervical cancer cells.
Visagie MH; Jaiswal SR; Joubert AM
Biol Res; 2016 Nov; 49(1):43. PubMed ID: 27806731
[TBL] [Abstract][Full Text] [Related]
5. Intracellular Signaling Responses Induced by Radiation within an In Vitro Bone Metastasis Model after Pre-Treatment with an Estrone Analogue.
Helena J; Joubert A; Mabeta P; Coetzee M; Lakier R; Mercier A
Cells; 2021 Aug; 10(8):. PubMed ID: 34440874
[TBL] [Abstract][Full Text] [Related]
6. Combination of radiation and celebrex (celecoxib) reduce mammary and lung tumor growth.
Liu W; Chen Y; Wang W; Keng P; Finkelstein J; Hu D; Liang L; Guo M; Fenton B; Okunieff P; Ding I
Am J Clin Oncol; 2003 Aug; 26(4):S103-9. PubMed ID: 12902866
[TBL] [Abstract][Full Text] [Related]
7. Coenzyme Q
Wang HM; Yang HL; Thiyagarajan V; Huang TH; Huang PJ; Chen SC; Liu JY; Hsu LS; Chang HW; Hseu YC
Integr Cancer Ther; 2017 Sep; 16(3):385-396. PubMed ID: 27821721
[TBL] [Abstract][Full Text] [Related]
8. In vitro evaluation of ESE-15-ol, an estradiol analogue with nanomolar antimitotic and carbonic anhydrase inhibitory activity.
Stander BA; Joubert F; Tu C; Sippel KH; McKenna R; Joubert AM
PLoS One; 2012; 7(12):e52205. PubMed ID: 23300615
[TBL] [Abstract][Full Text] [Related]
9. AT-101, a pan-Bcl-2 inhibitor, leads to radiosensitization of non-small cell lung cancer.
Moretti L; Li B; Kim KW; Chen H; Lu B
J Thorac Oncol; 2010 May; 5(5):680-7. PubMed ID: 20354451
[TBL] [Abstract][Full Text] [Related]
10. Dysregulation of Catalase by a Sulphamoylated Estradiol Analogue Culminates in Antimitotic Activity and Cell Death Induction in Breast Cancer Cell Lines.
Lebelo MT; Joubert AM; Visagie MH
Molecules; 2021 Jan; 26(3):. PubMed ID: 33504098
[TBL] [Abstract][Full Text] [Related]
11. Oridonin Enhances Radiation-Induced Cell Death by Promoting DNA Damage in Non-Small Cell Lung Cancer Cells.
Park H; Jeong YJ; Han NK; Kim JS; Lee HJ
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30104472
[TBL] [Abstract][Full Text] [Related]
12. A Combination of an Antimitotic and a Bromodomain 4 Inhibitor Synergistically Inhibits the Metastatic MDA-MB-231 Breast Cancer Cell Line.
Mqoco T; Stander A; Engelbrecht AM; Joubert AM
Biomed Res Int; 2019; 2019():1850462. PubMed ID: 31886177
[TBL] [Abstract][Full Text] [Related]
13. Ionizing radiation sensitizes breast cancer cells to Bcl-2 inhibitor, ABT-737, through regulating Mcl-1.
Wu H; Schiff DS; Lin Y; Neboori HJ; Goyal S; Feng Z; Haffty BG
Radiat Res; 2014 Dec; 182(6):618-25. PubMed ID: 25409124
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of ionizing radiation response by histamine in vitro and in vivo in human breast cancer.
Martinel Lamas DJ; Cortina JE; Ventura C; Sterle HA; Valli E; Balestrasse KB; Blanco H; Cremaschi GA; Rivera ES; Medina VA
Cancer Biol Ther; 2015; 16(1):137-48. PubMed ID: 25482934
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol enhances ionizing radiation-induced premature senescence in lung cancer cells.
Luo H; Wang L; Schulte BA; Yang A; Tang S; Wang GY
Int J Oncol; 2013 Dec; 43(6):1999-2006. PubMed ID: 24141489
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of enhanced radiation response following epidermal growth factor receptor signaling inhibition by erlotinib (Tarceva).
Chinnaiyan P; Huang S; Vallabhaneni G; Armstrong E; Varambally S; Tomlins SA; Chinnaiyan AM; Harari PM
Cancer Res; 2005 Apr; 65(8):3328-35. PubMed ID: 15833866
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibody to HER-2/neureceptor modulates repair of radiation-induced DNA damage and enhances radiosensitivity of human breast cancer cells overexpressing this oncogene.
Pietras RJ; Poen JC; Gallardo D; Wongvipat PN; Lee HJ; Slamon DJ
Cancer Res; 1999 Mar; 59(6):1347-55. PubMed ID: 10096569
[TBL] [Abstract][Full Text] [Related]
18. Overcoming the radioresistance of prostate cancer cells with a novel Bcl-2 inhibitor.
An J; Chervin AS; Nie A; Ducoff HS; Huang Z
Oncogene; 2007 Feb; 26(5):652-61. PubMed ID: 16909121
[TBL] [Abstract][Full Text] [Related]
19. ANTP-SmacN7 fusion peptide-induced radiosensitization in A549 cells and its potential mechanisms.
Zhang R; Sun H; Wang H; Zhang W; Geng K; Liu Q; Wang P
Thorac Cancer; 2020 May; 11(5):1271-1279. PubMed ID: 32155687
[TBL] [Abstract][Full Text] [Related]
20. Ultrastructural changes of erythrocytes in whole blood after exposure to prospective in silico-designed anticancer agents: a qualitative case study.
Repsold L; Mqoco T; Wolmarans E; Nkandeu S; Theron J; Piorkowski T; Toit Pd; Papendorp Dv; Joubert AM
Biol Res; 2014 Sep; 47(1):39. PubMed ID: 25299962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
